NCT00598351 2026-03-11
Natural History Study of Patients With Neurofibromatosis Type 2
National Institutes of Health Clinical Center (CC)
Recruiting
Clinical Trials
14 trialsNCT04278118 2026-02-17
HiPPI
Emory University
Phase NA Recruiting
NCT05139277 2026-02-06
Evaluation of the CONVIVO System
Dartmouth-Hitchcock Medical Center
Phase NA Recruiting
NCT06322342 2025-12-26
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Reveal Pharmaceuticals Inc.
Phase 2 Completed
NCT01083966 2025-04-09
Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma
Northwell Health
Phase 1 Suspended
NCT05254197 2024-12-03
SOLOMON
Seoul National University Hospital
Recruiting
NCT04648462 2024-11-26
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Maastricht Radiation Oncology
Recruiting
NCT06112509 2024-09-19
EVERS
Centre Hospitalier Universitaire de Besancon
Phase NA Recruiting
NCT05576103 2024-06-18
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
University of California, San Diego
Recruiting
NCT04712214 2023-04-25
Use of Non-invasive Optical Analysis in Neurosurgery
Imperial College London
Phase NA Unknown
NCT01347307 2020-06-18
Stereotactic Body Radiotherapy for Spine Tumors
Mercy Research
Phase NA Completed
NCT02988726 2017-07-26
Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma
Burzynski Research Institute
Phase 2 Terminated
NCT00973739 2016-03-22
Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
NYU Langone Health
Phase 2 Completed
NCT00340496 2008-03-04
Analysis of NF2 Mutations in Radiation-Related Neural Tumors
National Institutes of Health Clinical Center (CC)
Completed